Newer Diabetes Drugs Could Boost Risk for Gallbladder and Bile Duct Disease (FREE)

By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Use of glucagon-like peptide 1 (GLP-1) receptor agonists is associated with increased risk for gallbladder and bile duct …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news